Division of Cancer Immunotherapy (Kashiwa), NCC

Japan

1 December 2019 - 30 November 2020

No articles found. Division of Cancer Immunotherapy (Kashiwa), NCC did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

National Cancer Center (NCC)
↳ Exploratory Oncology Research and Clinical Trial Center, NCC
↳ Division of Cancer Immunotherapy (Kashiwa), NCC
Division of Pathology, NCC
Division of Translational Research, NCC
Center for Cancer Control and Information Services, NCC
Center for Cancer Genomics and Advanced Therapeutics (C-CAT), NCC
Division of Epidemiology, NCC
Department of Breast and Medical Oncology, National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital
Department of Genetic Medicine and Services, National Cancer Center Hospital
Department of Gynecology, National Cancer Center Hospital
Division of Thoracic Oncology, NCC
Research Center for Innovative Oncology, NCC
Cancer Proteomics for Biomarker Development, NCC
Division of Cancer Differentiation, NCC
Division of Cancer Genomics, NCC
Division of Cancer Pathophysiology, NCC
Division of Chemotherapy and Clinical Research, NCC
Division of Epigenomics, NCC
Division of Genetics, NCC
Division of Genome Biology, NCC
Division of Hematological Malignancy, NCC
Division of Molecular Oncology, NCC
Division of Molecular and Cellular Medicine, NCC
Division of Refractory and Advanced Cancer, NCC
Department of Clinical Genomics, NCC
Division of Rare Cancer Research, NCC
Laboratory of Fundamental Oncology, NCC
Research Center for Cancer Prevention and Screening, NCC
Tsuruoka Metabolomics Laboratory, NCC

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER